Fall / Winter 2025 | From the CEO 3
“ The road ahead is demanding. Parkinson’ s is a complex condition, and there is no one-size-fits-all solution. But we’ re better positioned than ever, and we’ re not slowing down.”
Parkinson’ s in living people. This breakthrough is advancing earlier detection and prevention strategies for Parkinson’ s and other parkinsonisms, while also shedding light on important biological overlaps with other brain diseases like Alzheimer’ s. By identifying common pathways across conditions, we’ re uniting the field of neurodegenerative research and accelerating progress on multiple fronts. As you’ ll learn on page 8, a win in one area is increasingly a win for all— and that momentum is building.
To each of you reading this: thank you. Whether you have supported this work from the very beginning or are just joining our community, you are part of a united effort that is transforming what’ s possible for people and families with Parkinson’ s. You are helping to ensure that our next five years are even more impactful than our first 25.
With gratitude,
Of course, the road ahead is demanding. Parkinson’ s is a complex condition, and there is no one-size-fits-all solution. But we’ re better positioned than ever, and we’ re not slowing down. We are rallying the global community around this moment, inviting more people into the mission and accelerating research across every front.
Debi Brooks, CEO and Co-Founder